Position in CYTK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$316,267,959
+$104,339,957 QoQ
Shares Held
3,712,501
+15.5% QoQ
Ownership
2.67%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#10
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. CYTK ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,267,959 | 3,712,501 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $211,928,002 | 3,215,415 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $194,179,319 | 3,056,017 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $167,089,501 | 3,040,202 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $98,936,462 | 2,994,445 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $118,057,481 | 2,937,484 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $133,656,539 | 2,841,338 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $150,405,234 | 2,848,584 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $148,379,839 | 2,738,646 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $157,548,738 | 2,247,165 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $174,504,536 | 2,090,125 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $58,282,632 | 1,978,365 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $62,279,115 | 1,909,231 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $61,043,952 | 1,734,696 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $75,962,687 | 1,657,850 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $77,106,140 | 1,591,458 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $58,287,579 | 1,483,522 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $54,181,043 | 1,471,911 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $65,116,590 | 1,428,622 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $49,966,235 | 1,398,048 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $23,954,251 | 1,210,422 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $26,938,057 | 1,158,128 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $21,934,557 | 1,055,561 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $21,713,780 | 1,002,946 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $20,531,025 | 871,066 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $10,112,942 | 857,756 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||